Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Completed 116 enrolled National Institute of Allergy and Infectious Diseases (NIAID) Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Men's and women's bodies may process anti-HIV drugs differently. The purpose of this study is to determine the differences in blood levels of soft gel capsules and tablets of lopinavir/ritonavir (LPV/r) in HIV infected men and women.

Timeline

Start: 2005-10
Primary completion: —
Completion: 2007-07

Publications

Background Umeh OC, Currier JS. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005 Jan;7(1):73-78. doi: 10.1007/s11908-005-0026-9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lopinavir/ritonavir	Unknown	—	—

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Summary

Timeline

Publications

Drugs

Indications